Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 102 of the 104 references it cites were found in a registry or an index.
Abstract
Reversal of type 2 diabetes to normal metabolic control by either bariatric surgery or hypocaloric diet allows for the time sequence of underlying pathophysiologic mechanisms to be observed. In reverse order, the same mechanisms are likely to determine the events leading to the onset of hyperglycemia and permit insight into the etiology of type 2 diabetes. Within 7 days of instituting a substantial negative calorie balance by either dietary intervention or bariatric surgery, fasting plasma glucose levels can normalize. This rapid change relates to a substantial fall in liver fat content and return of normal hepatic insulin sensitivity. Over 8 weeks, first phase and maximal rates of insulin secretion steadily return to normal, and this change is in step with steadily decreasing pancreatic fat content. The difference in time course of these two processes is striking. Recent information on the intracellular effects of excess lipid intermediaries explains the likely biochemical basis, which simplifies both the basic understanding of the condition and the concepts used to determine appropriate management. Recent large, long-duration population studies on time course of plasma glucose and insulin secretion before the diagnosis of diabetes are consistent with this new understanding. Type 2 diabetes has long been regarded as inevitably progressive, requiring increasing numbers of oral hypoglycemic agents and eventually insulin, but it is now certain that the disease process can be halted with restoration of normal carbohydrate and fat metabolism. Type 2 diabetes can be understood as a potentially reversible metabolic state precipitated by the single cause of chronic excess intraorgan fat. Type 2 diabetes has long been known to progress despite glucose-lowering treatment, with 50% of individuals requiring insulin therapy within 10 years (1). This seemingly inexorable deterioration in control has been interpreted to mean that the condition is treatable but not curable. Clinical guidelines recognize …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three approaches show a similar time-course with glycemic control preceding weight loss by weeks or months, suggesting potential overlap of mechanisms (11, 12).”
From Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial (2019) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In controlled clinical trials, each approach has demonstrated improved glycemic control and CVD risk factors, reduced pharmaceutical dependence, and weight loss.”
From Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial (2019) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“It has been estimated that 50% of patients require insulin therapy within 10 years of T2D diagnosis.245”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [245]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“When a variant of PNPLA3was described as determining increased hepatic fat levels, it appeared that a major factor underlying nonalcoholic fatty liver disease and insulin resistance was identified (55).”
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“Although a defect in mitochondrial function is associated with extremes of insulin resistance in skeletal muscle (30), this does not appear to be relevant to the etiology of type 2 diabetes.”
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
Long-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · cited 1×
“Hypocaloric diet (42), physical activity (43), or thiazolidinedione use (23,44) each reduces insulin secretion and decreases liver fat content.”
Cited by
Items 401–487 of 487
Nana, M., Moore, S. L., Loganathan, R., Williams, V., Rahman, M., Jennings, E., Dixon, A., & Bondugulapati, L. N. R. (2021) · British Journal of Diabetes · doi:10.15277/bjd.2021.316 · Cited by 1
Type 2 diabetes: weight loss, exercise and other ‘lifestyle’ interventions
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch9
Bishop, D. B., O’Connor, P. J., Kidney, R. S. M., & Haire-Joshu, D. L. (2016) · American Public Health Association eBooks · doi:10.2105/9780875532783ch12
Introduction to Obesity and Obesity‐Related Diseases
IDRIS, I. R. (2022) · doi:10.1002/9781119521686.ch1
Vihari, J., Sriteja, N., Sahu, S., Das, C., Sahoo, A. K., Swain, B., Vardhan, M. V., Jasthi, L. B., Elika, M., & Thammineni, R. (2023) · Medicine India · doi:10.25259/medindia_7_2022 · Cited by 3
Eriş, D. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2576
Ertracht, O., Saad, R., Tadmor, H., Nakhoul, F. M., & Nakhoul, N. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad063c_2601
Aranda-Ventura, J., Villacrés-Vallejo, J., Núñez-Tuesta, L., & González-Aspajo, G. (2020) · Revista Peruana de Medicina Integrativa · doi:10.26722/rpmi.2020.v5n4.248
Effects of dietary lipid intake on diabetes
Kadegowda, A. K. G., & Yu, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15327-3.00006-9
Li, C., Liu, Y., Lan, Y., & Wang, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3552461/v1
Arjunan, D., Ghosh, J., Hussain, S., Kumar, P., Antaal, R. S., Mukherjee, S., Walia, R., & Bhadada, S. K. (2023) · IJEM Case Reports · doi:10.4103/ijemcr.ijemcr_44_23
Management of type 2 diabetes after metabolic bariatric surgery
Tham, K. W., & Lee, P. C. (2023) · Mini-invasive Surgery · doi:10.20517/2574-1225.2023.80 · Cited by 1
Teasdale, S., Dong, X., Griffin, A., Clark, P. J., Nisbet, J., Morton, A., Phillips, L. K., Sullivan, M. A., & Galloway, G. J. (2024) · Research Square · doi:10.21203/rs.3.rs-3881186/v1
The Whole Human Pancreas: An Understudied Organ in Diabetes
Taylor, R. (2024) · Diabetes · doi:10.2337/dbi23-0021
Self-citationPoint-of-care Glycated Hemoglobin (POC-A1c) Testing Helps Early Diagnosis of Diabetes
Agrawal, R. P. (2024) · International journal of clinical metabolism and diabetes. · doi:10.1177/30502071241256261
Li, C., Liu, Y.-K., Lan, Y., & Wang, Z. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i20.4272 · Cited by 1
Why Are Doctors Not Interested in Type 2 Diabetes Mellitus Remission?
Jin, H. Y., & Park, T. S. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0312
Bardaweel, S. K., Banihani, S. A., & Al-Barghouthy, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_13
Remission of type 2 diabetes mellitus through intensive lifestyle modification in ambulatory setting
Antony, A., Behera, P., Patro, B. K., & Taywade, M. (2024) · Indian Journal of Community and Family Medicine · doi:10.4103/ijcfm.ijcfm_26_24
Liu, S., Lei, Z., Huang, G., Zhang, L., Luo, W., & Yang, J. (2025) · Medicine · doi:10.1097/md.0000000000041332
“[3] Diabetes is known to cause retinopathy, and numerous studies have explored the nexus between vision and diabetes.”
Alami, H. E., Bouqdayr, M., Errafii, K., Rhalem, W., Wakrim, L., Ettaki, I., Ghazal, H., Idrissi, N. A., Abidi, O., Bakkali, F., et al. (2025) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2025.2466429
Wang, H., Li, S., Zhao, T., Pan, X., & Wang, L. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2477074
The METTL Family in Metabolic Disease Regulation
刘, 一. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153833
The role of Tim-3+T cell subsets in the peripheral blood of patients with COVID-19 and diabetes
Luo, W., Zhao, M., Gu, M., Huang, J., Wu, S., & Zhao, B. (2025) · iScience · doi:10.1016/j.isci.2025.112339
Clinical Characteristics of Korean Patients with Youth-Onset Type 2 Diabetes Mellitus in Remission
Shin, S., Kim, H. Y., Kim, S. Y., & Kim, J. H. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24042 · Cited by 1
Impact of Copper/Zinc Ratio in Diabetic Retinopathy and Nephropathy: A Cross-Sectional Study
Mansouri, M., Azizi, R., Namiranian, N., & Ardakani, M. A. (2025) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambr.33.156.11
王, 媛. (2025) · Traditional Chinese Medicine · doi:10.12677/tcm.2025.144245
Diabetes reversal: Hope, hype, and the real
Prasad, G. S. (2025) · Medicover journal of medicine. · doi:10.4103/mjm.mjm_9_25
Die Metabolismus-assoziierte Lebererkrankung (MASLD)
Walle, H. (2025) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-2608-2533
Luo, Z., Zhang, Z., Zheng, Y., Gao, Q., Wang, Y., & Liu, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5339508
Fadini, G. P., Giaccari, A., Broglio, F., Nollino, L., Fattor, B., Anichini, R., Meregalli, G., Avogaro, A., Consoli, A., & GLIMPLES Study Investigators (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5347795
Alqahtani, N. S., & Alenezi, A. (2025) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.13.2.7
Liu, R., Zou, L., Wang, M., He, Y., Liu, X., Yang, W., & Shu, M. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11344-x
Die Metabolismus-assoziierte Lebererkrankung (MASLD)
Walle, H. (2025) · Zeitschrift für Komplementärmedizin · doi:10.1055/a-2695-5935
Impact of oxidative stress on confluent diabetes and Alzheimer's disease
Ardhra, P. B., Thankachan, C., Devikrishna, P. R., Joshi, Y., & George, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00003-9
Zeng, K., Chen, B., Li, H., Ren, N., Song, Y., Liang, M., Yin, Y., Huang, Y.-L., Liu, T., Lin, Y., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100436
“These findings align with emerging paradigms of diabetes reversal [24] and highlight the potential of multidisciplinary care.”
Liu, T., Sun, P., Zou, J., Wang, L., Wang, G., Liu, N., Liu, Y., Ding, X., Zhang, B., Liang, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14211381
Lu, Y.-W., Chang, C.-C., Chou, R.-H., Tsai, Y.-L., Liu, L.-K., Chen, L.-K., Huang, P.-H., & Lin, S.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16807817
Kashiwagi-Takayama, R., Kozawa, J., Hosokawa, Y., Kato, S., Kawata, S., Ozawa, H., Mineo, R., Ishibashi, C., Baden, M. Y., Iwamoto, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619209
Guan, J., Liu, T., Yang, K., & Chen, H. (2024) · Figshare · doi:10.6084/m9.figshare.26241318
Guan, J., Liu, T., Yang, K., & Chen, H. (2024) · Figshare · doi:10.6084/m9.figshare.26747690
Li, T., Ling, J., Du, X., Zhang, S., Yang, Y., & Zhang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644333
Li, T., Ling, J., Du, X., Zhang, S., Yang, Y., & Zhang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644336
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Figshare · doi:10.6084/m9.figshare.20218954
Li, T., Ling, J., Du, X., Zhang, S., Yang, Y., & Zhang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644330
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361947
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361935
Guan, J., Liu, T., Yang, K., & Chen, H. (2024) · Figshare · doi:10.6084/m9.figshare.26747687
Lu, Y.-W., Chang, C.-C., Chou, R.-H., Tsai, Y.-L., Liu, L.-K., Chen, L.-K., Huang, P.-H., & Lin, S.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16807820
Guan, J., Liu, T., Yang, K., & Chen, H. (2024) · Figshare · doi:10.6084/m9.figshare.26241138
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361932
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361944
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361929
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361941
Khalaji, A., Behnoush, A. H., Saeedian, B., Khanmohammadi, S., Varniab, Z. S., & Peiman, S. (2024) · Figshare · doi:10.6084/m9.figshare.26589783
Li, M., Li, X., Xu, L., Xiao, P., Ma, P., & Yue, L. (2025) · Advanced Chinese Medicine · doi:10.1002/acm4.70005
“Type 2 diabetes mellitus (T2DM) is defined by peripheral insulin resistance and chronic hyperglycemia [2].”
Semaan, L. B., Kalani, K., Saleh, M. H. A., Ray, B., Ghataliya, P., Abulatifa, H., & Wang, H.-L. (2025) · BMC Oral Health · doi:10.1186/s12903-025-07086-9
Bock, F. M., Dong, X., Ghoshal, K., Cappel, D. A., Deaver, J. W., Lark, D., Cozzani, L., Bracy, D. P., Lantier, L., Allison, D. O., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102322
Li, Q., Liu, X., Xiao, L., Cui, Z., Kou, N., Zhu, X., & Li, F. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110772
Dhaigude, P., Neema, A., Shamsi, S., Sethi, D., John, S. J., Khetan, M., & Kalhan, S. (2025) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_8_25
Jørgensen, F. K., Mohanty, A., Kieler, I. N., Xia, D., Wallace, M. D., Rasmussen, M. H., van der Merwe, T., Broughton, S., Nybroe, S., Hookey, T., et al. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalag040
Fuel toxicity-associated spectrum (FTAS): a unifying nomenclature for metabolic disorders
Sureshkumar, P. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00282-8
Α-gustducine intestinale : implication dans l'obésité et le diabète de type 2
Gléau, L. L. (2021) · theses.fr (ABES) · doi:10.70675/dc436e75zb6d2z4bb4zb9a1z17b025f205a6
Abdelaziz, S., Kassem, K. F., & salah, M. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.16.718956
Type 2 diabetes as a disease of progressive loss of individual adipose storage capacity
Khalleefah, A. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.111991
Kaya, D. E., Arıkoğlu, H., Göktürk, F., İşçioğlu, F., & İpekçi, S. H. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12184-0
Zhao, Y., Zhang, H., Wang, H., Ma, L., Chimedtseren, C., Urtnasan, M., Wang, M., Xiang, W., & Li, M. (2026) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000115
Chen, Y., Shi, Y., Zhang, X., Zhang, J.-Y., Zhang, S., Zhao, H., & Liu, D. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70386
“Treatment strategies emphasize comprehensive individualized management combining lifestyle modi fi cations with pharmacological interventions 5 .”
Bhattacharyya, S., Chatterjee, S., Jadhav, A., Patnala, S., Chakravarthy, R., Anantharaman, R., Somani, S., Pamnani, H., Chawla, P., Verma, S., et al. (2026) · Journal of Diabetology · doi:10.4103/jod.jod_202_25
NR4A1 negatively regulates ferroptosis of pancreatic β-cells induced by Erastin
Guo, W., Song, M., Wang, Y., Liu, X., Jin, M., & Pu, Z. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124613
McKay, B. M., Chaar, D. E., Sievenpiper, J. L., & Chiavaroli, L. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113466
Wang, P., Foo, N., Su, C., Leung, N. Y. T., Song, S. W., Seres, G., Sapanel, Y., Hooi, L., Wong, A., Ong, Y. H., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354234 · Cited by 2
“Prior studies have also shown that fasting may reduce hepatic fat, improve fasting insulin and glucose levels, as well as reduce inflammation [115,116].”
Li, Z., Wang, P., Wang, X., Pan, M., Zhao, J., Zhang, X., Wang, Z., Ma, W., & Liu, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122309
Poothullil, J. M. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.112129
Shi, L., Zhou, B., Hong, M., Wei, S., Liu, C., Yuan, Y., Hu, S., Duez, P., Faruque, M. O., Wei, Y., et al. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.08.007
Wei, P., Wang, Z., Luo, Q., Zhang, Y., Meng, X., & Wang, J. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02424-5
“The effects associated with oxidative stress encompass mitochondrial dysfunction, decreased body glucose tolerance, impaired islet cell function, and INS resistance, aggravating diabetes (Belosludtsev et al. 2020; Hudish et al. 2019; Taylor 2013).”
Berman, C., Vidmar, A. P., Garcia, J. F., Reid, M. W., Gonzalez, F., Sanchez, A. T., Salcedo-Rodriguez, E., & Raymond, J. K. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0087
Raut, S., Gawande, S., lanjekar, R., & Mahabhudhe, J. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100625
Influencing factors of type 2 diabetes remission: a systematic review and meta-analysis
Cheng, S., Chen, J., Zhang, X., Qi, H., Kang, X., Nie, W., Feng, Y., & Chen, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1916734
Jun, J. E., Ryu, H. J., Hwang, Y., Ahn, K. J., Chung, H. Y., Lee, S. J., Jeong, I., & Choi, S. I. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71455
Unpacking the pancreatic depot: can a dietary pattern modulate pancreatic fat beyond weight loss?
Gómez‐Ambrosi, J. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101576
Vital, V. (2013) · UA Campus Repository (The University of Arizona)
Lagger, G., Sittarame, F., Gay, V., Chambouleyron, M., Lasserre-Moutet, A., & Golay, A. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30153-x
Metadata
- Authors
- Taylor, R.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Taylor, Roy
- ORCID
- Taylor, Roy
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 36
- Issue
- 4
- Pages
- 1047-1055
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3609491
- OpenAlex
- W2051587831
- Cited by
- 485
- References
- 104
- Citations by year
- 2026: 39 · 2025: 63 · 2024: 67 · 2023: 35 · 2022: 35 · 2021: 65 · 2020: 33 · 2019: 28 · 2018: 25 · 2017: 24 · 2016: 26 · 2015: 16 · 2014: 22 · 2013: 4
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, diabetes remission, bariatric surgery, hypocaloric diet, hepatic insulin sensitivity, liver fat, pancreatic fat content, insulin secretion, disease progression, insulin resistance
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.